Challenges in Managing and Preventing Pain Clinical Research Center, University of Pittsburgh, Pittsburgh, Pennsylvania.
Division of General Internal Medicine, Center for Research on Health Care, University of Pittsburgh, Pittsburgh, Pennsylvania.
JAMA Netw Open. 2021 Sep 1;4(9):e2124511. doi: 10.1001/jamanetworkopen.2021.24511.
Over the last decade, cannabis has become more accessible through the proliferation of dispensaries in states that have legalized its use. Most patients using cannabis for medical purposes report getting advice from dispensaries, yet there has been little exploration of frontline dispensary staff practices.
To describe the practices of frontline dispensary workers who interact with customers purchasing cannabis for medical purposes and assess whether dispensary practices are associated with medicalization of state cannabis laws (degree to which they resemble regulation of prescription or over-the-counter drugs) and statewide adult use.
DESIGN, SETTING, AND PARTICIPANTS: This nationwide cross-sectional survey study was conducted from February 13, 2020, to October 2, 2020, using an online survey tool. Potential respondents were eligible if they reported working in a dispensary that sells tetrahydrocannabinol-containing products and interacting with customers about cannabis purchases.
Participant responses to questions about formulating customer recommendations and talking to customers about risks.
The 434 survey responses from 351 unique dispensaries were most often completed by individuals who identified as budtenders (40%), managers (32%), and pharmacists (13%). Most respondents reported basing customer recommendations on the customer's medical condition (74%), the experiences of other customers (70%), the customer's prior experience with cannabis (67%), and the respondent's personal experience (63%); fewer respondents relied on clinician input (40%), cost (45%), or inventory (12%). Most respondents routinely advised customers about safe storage and common adverse effects, but few counseled customers about cannabis use disorder, withdrawal, motor vehicle collision risk, or psychotic reactions. A higher state medicalization score was significantly associated with using employer training (odds ratio, 1.41; 95% CI, 1.18-1.67) and physician or clinician input (odds ratio, 1.23; 95% CI, 1.05-1.43) as a basis for recommendation. Medicalization score was not associated with counseling about cannabis risks.
This survey study provides insight into how frontline dispensary staff base cannabis recommendations and counsel about risks. The findings may have utility for clinicians to counsel patients who purchase cannabis, customers who want to be prepared for a dispensary visit, and policy makers whose decisions affect cannabis laws.
在过去的十年中,随着允许使用大麻的州中大麻药房的普及,大麻的获取变得更加容易。大多数出于医疗目的使用大麻的患者都从药房获得建议,但对一线药房工作人员的实践经验却鲜有探索。
描述与购买医用大麻的顾客互动的一线药房工作人员的实践情况,并评估药房的做法是否与州医用大麻法规的医学化(即与处方药或非处方药的监管程度相似)和全州成人使用大麻有关。
设计、地点和参与者:这项全国性的横断面调查研究于 2020 年 2 月 13 日至 10 月 2 日期间使用在线调查工具进行,潜在的受访者如果报告在销售含有四氢大麻酚产品的药房工作,并与顾客就大麻购买问题进行交流,则有资格参加。
参与者对制定顾客建议和与顾客讨论风险的问题的回答。
来自 351 家不同药房的 434 份调查回复主要由以下人员填写:花商(40%)、经理(32%)和药剂师(13%)。大多数受访者表示,他们的顾客建议基于顾客的医疗状况(74%)、其他顾客的经验(70%)、顾客以前使用大麻的经验(67%)和受访者自己的经验(63%);较少的受访者依赖于临床医生的意见(40%)、成本(45%)或库存(12%)。大多数受访者经常建议顾客安全储存和常见的不良反应,但很少建议顾客注意大麻使用障碍、戒断、机动车碰撞风险或精神病反应。较高的州医用大麻评分与使用雇主培训(优势比,1.41;95%置信区间,1.18-1.67)和医生或临床医生的意见(优势比,1.23;95%置信区间,1.05-1.43)作为推荐依据显著相关。医用大麻评分与大麻风险咨询无关。
这项调查研究提供了关于一线药房工作人员如何根据大麻推荐和咨询风险的见解。这些发现可能对向购买大麻的患者、准备去药房的顾客以及影响大麻法规的政策制定者提供有用的参考。